Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates QNCX Bearish with a Setup Score of 33, net conviction 28, actionability 38. How the Setup Score works →
Total Setup Score
33
Directional Bias
Bearish
Net Conviction
28
Actionability
38 (in range)
Key signals behind this score
40wk Downtrend — falling+below (sma 158 vs px 30.55)
Fresh Breakdown — 80wk turn 22w+40wk turn 27w
80wk Downtrend — falling+below (sma 234 vs px 30.55)
200wk Downtrend — falling+below (sma 232 vs px 30.55)
RS Breakdown — momZ +0.31 · low 9w×1.00 · vs industry
About Quince Therapeutics, Inc.
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: May 9, 2019
Headquarters: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$25.74
Near-term / short-term trend
Weekly
40-Week SMA
$158.11
Medium-term trend
Weekly
80-Week SMA
$233.51
Cyclical trend (business cycle)
Weekly
200-Week SMA
$232.37
Secular trend (multi-year)
Monthly
10-Month SMA
$90.33
Near-term monthly trend
Monthly
20-Month SMA
$213.06
Medium-term monthly trend
Monthly
40-Month SMA
$224.85
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Quince Therapeutics, Inc.
(QNCX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.